Software Refraction With Mobilerone Versus Retinoscopy
Recruiting
N/A
Interventional Study
Myopia
Myopia, Moderate
Astigmatism
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 10 – 46
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 120 (estimated)
- Sponsor
- Beijing Airdoc Technology Co., Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Software refraction in the mobilerone for myopia and astigmatism is a novel medical device for myopia adults and elder children with or without astigmatism. And the investigators would like to test its accuracy and efficacy as well as safety.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* • subject with ametropia on each eye ≤-12.00D
* subject with best corrected visual acuity ≥ 20/25, no amblyopia
* subject with normal transparency of eyes
* subject with a healthy fundus that does not reveal major abnormalities that may affect vision due to the fluctuat…
Contacts
No contact information available.